CCDC142 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.331800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.473600E-01
Normal-vs-Stage2
1.042850E-01
Normal-vs-Stage3
2.181600E-01
Normal-vs-Stage4
5.137200E-01
Stage1-vs-Stage2
2.074400E-01
Stage1-vs-Stage3
8.939700E-02
Stage1-vs-Stage4
5.909200E-01
Stage2-vs-Stage3
4.294200E-01
Stage2-vs-Stage4
7.097200E-01
Stage3-vs-Stage4
4.936200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.355810E-01
Normal-vs-AfricanAmerican
4.069200E-01
Normal-vs-Asian
2.922000E-01
Caucasian-vs-AfricanAmerican
7.559600E-01
Caucasian-vs-Asian
8.087600E-01
AfricanAmerican-vs-Asian
7.421600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.955700E-02
Normal-vs-Female
2.166400E-01
Male-vs-Female
4.390600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.691800E-01
Normal-vs-Age(41-60Yrs)
2.447200E-01
Normal-vs-Age(61-80Yrs)
1.074220E-01
Normal-vs-Age(81-100Yrs)
2.258800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.914800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.241700E-04
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.243600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.574200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.511200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.339800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.042100E-02
Normal-vs-Daily Drinker
1.643560E-01
Normal-vs-Weekly Drinker
1.986050E-01
Normal-vs-Occasional Drinker
5.482000E-01
Normal-vs-Social Drinker
2.281800E-01
Non Drinker-vs-Daily Drinker
4.841400E-01
Non Drinker-vs-Weekly Drinker
4.506000E-01
Non Drinker-vs-Occasional Drinker
1.446800E-01
Non Drinker-vs-Social Drinker
1.086170E-01
Daily Drinker-vs-Weekly Drinker
9.207600E-01
Daily Drinker-vs-Occasional Drinker
3.318000E-01
Daily Drinker-vs-Social Drinker
4.565000E-01
Weekly Drinker-vs-Occasional Drinker
4.450800E-01
Weekly Drinker-vs-Social Drinker
5.470000E-01
Occasional Drinker-vs-Social Drinker
7.067000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.296800E-01
Normal-vs-Grade 2
1.971630E-01
Normal-vs-Grade 3
1.485410E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.993600E-01
Grade 1-vs-Grade 3
2.093800E-01
Grade 1-vs-Grade 4
5.296800E-01
Grade 2-vs-Grade 3
4.228000E-01
Grade 2-vs-Grade 4
1.971630E-01
Grade 3-vs-Grade 4
1.485410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.368300E-02
Normal-vs-NonDiabetic
2.059000E-01
Diabetic-vs-NonDiabetic
5.935600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.661400E-01
Normal-vs-NoPancreatitis
1.242010E-01
Pancreatitis-vs-NoPancreatitis
2.269800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.900800E-01
Normal-vs-N1
9.154200E-02
N0-vs-N1
2.559200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.874400E-01
Normal-vs-TP53-NonMutant
3.592800E-01
TP53-Mutant-vs-TP53-NonMutant
5.753400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
